Aviragen Therapeutics's competitors

Aviragen Therapeutics's competitors include Biogen, Athersys, Ironwood Pharmaceuticals and Threshold Pharmaceuticals
Add company...
Aviragen Therapeutics
Aviragen Therapeutics is focused on the discovery and development of direct-acting antivirals to treat infections that have limited therapeutic options and affect a significant number of patients globally.
Biogen
Biogen develops, markets and manufactures therapies for people living with serious neurological, autoimmune and rare diseases.
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Threshold Pharmaceuticals
Threshold Pharmaceuticals is focused on the development of drugs targeting Tumor Hypoxia, a low oxygen condition found in solid tumors.
Founding Date
Founding Date
1969
Founding Date
1978
Founding Date
1995
Founding Date
N/A
Founding Date
2001
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Alpharetta, US HQ
Locations
Cambridge, US HQ
Locations
Cleveland, US HQ
Canton, US
Locations
Cambridge, US HQ
Locations
South San Francisco, US HQ
Employees
Employees
21
Employees
7,3001% decrease
Employees
60
Employees
674
Employees
1512% decrease
Valuation ($)
Valuation ($)
24 m
Valuation ($)
58.3 b
Valuation ($)
309 m
Valuation ($)
2.8 b
Valuation ($)
223.6 m
Facebook likes
Facebook likes
N/A
Facebook likes
3.1 k
Facebook likes
475
Facebook likes
18
Facebook likes
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
19.4 k
Twitter followers
953
Twitter followers
3.1 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$11.4b (FY, 2016)
Revenue (est.)
$3.7m (FY, 2017)
Revenue (est.)
$274m (FY, 2016)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
$3.7b (FY, 2016)
Net income
N/A
Net income
($81.7m) (FY, 2016)
Net income
($24.1m) (FY, 2016)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 9m
Total funding raised
$ 284m
Total funding raised
$ 49.3m
For sources of this data, please see the company profileDownload Excel

View company profiles

Biogen
HQ
Cambridge, US
Employees
7,300↓ 1% decrease

Biogen develops, markets and manufactures therapies for people living with serious neurological, autoimmune and rare diseases.

View company
Athersys
HQ
Cleveland, US
Employees
60

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company
Ironwood Pharmaceuticals
HQ
Cambridge, US
Employees
674

Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.

View company
Threshold Pharmaceuticals
HQ
South San Francisco, US
Employees
15↓ 12% decrease

Threshold Pharmaceuticals is focused on the development of drugs targeting Tumor Hypoxia, a low oxygen condition found in solid tumors.

View company